To further explore the CD103+ CD8 TIL subset, we examined the expression of CD39, PD-1, CD127, and additional cell surface markers associated with activation/exhaustion in a patient with head and neck squamous cell carcinoma (HNSCC). This evidence concerns the gene IL7R and head and neck squamous cell carcinoma.